In both NAFLD and NASH, patients exhibit increased circulating IFNγ-producing TH1 cells, and patients with NASH could be stratified from those with NAFLD by the increase in circulating TH17 cells [143]. This evidence concerns the gene IFNG and metabolic dysfunction-associated steatotic liver disease.